---
figid: PMC3096079__AHC10029f01
figlink: /pmc/articles/PMC3096079/figure/F1/
number: F1
caption: mTOR regulation pathway involved in hypoxia. Everolimus combines with FKBP12,
  and obstructs the function of mTOR. p-mTOR (phosphorylated-mTOR) is inhibited by
  everolimus. Inhibition of mTOR increases the binding of 4E-BP1 to elF-4E, consequently
  leading to inactivation of HIF-1α mRNA translation. HIF-1 composed of α unit and
  β unit binds to hypoxia response elements (HREs), resulting in the upregulation
  of hypoxia-related factors such as VEGF (vascular endothelial growth factor), GLUT-1
  (glucose transporter-1), and EPO (erythropoietin).
pmcid: PMC3096079
papertitle: Analysis of mTOR Inhibition-Involved Pathway in Ovarian Clear Cell Adenocarcinoma.
reftext: Makiko Harasawa, et al. Acta Histochem Cytochem. 2011 Apr 28;44(2):113-118.
pmc_ranked_result_index: '79628'
pathway_score: 0.9132356
filename: AHC10029f01.jpg
figtitle: mTOR regulation pathway involved in hypoxia
year: '2011'
organisms: Homo sapiens
ndex: f19dc1c3-df10-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3096079__AHC10029f01.html
  '@type': Dataset
  description: mTOR regulation pathway involved in hypoxia. Everolimus combines with
    FKBP12, and obstructs the function of mTOR. p-mTOR (phosphorylated-mTOR) is inhibited
    by everolimus. Inhibition of mTOR increases the binding of 4E-BP1 to elF-4E, consequently
    leading to inactivation of HIF-1α mRNA translation. HIF-1 composed of α unit and
    β unit binds to hypoxia response elements (HREs), resulting in the upregulation
    of hypoxia-related factors such as VEGF (vascular endothelial growth factor),
    GLUT-1 (glucose transporter-1), and EPO (erythropoietin).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARNT
  - SLC2A1
  - VEGFC
  - SETD2
  - VHL
  - FKBP1A
  - AKT1
  - AKT3
  - EIF4EBP1
  - MTOR
  - EPO
  - EIF4E
  - VEGFB
  - PGF
  - AKT2
  - VEGFA
  - VEGFD
genes:
- word: HIF-1B
  symbol: HIF-1beta
  source: hgnc_alias_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: GLUT-1,
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: FKBP12
  symbol: FKBP-12
  source: hgnc_alias_symbol
  hgnc_symbol: FKBP1A
  entrez: '2280'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: EPO
  symbol: EPO
  source: hgnc_symbol
  hgnc_symbol: EPO
  entrez: '2056'
- word: EIF4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
chemicals: []
diseases: []
figid_alias: PMC3096079__F1
redirect_from: /figures/PMC3096079__F1
figtype: Figure
---
